Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Pharmaceutic-company

MAIDEN PHARMACEUTICALS-WHO/INDIA
RTSBUSF6 
October 06, 2022 
Logo of the Maiden Pharmaceuticals Ltd. company is seen on a board outside their office in New Delhi,... 
New Delhi, India 
Logo of the Maiden Pharmaceuticals Ltd. company is seen on a board put up outside their office in New... 
Logo of the Maiden Pharmaceuticals Ltd. company is seen on a board outside their office in New Delhi, India, October 6, 2022. REUTERS/Anushree Fadnavis 
MAIDEN PHARMACEUTICALS-WHO/INDIA
RTSBUSEU 
October 06, 2022 
A cameraman takes visuals outside the office of Maiden Pharmaceuticals Ltd. company, in New Delhi, India,... 
New Delhi, India 
A cameraman takes visuals outside the office of Maiden Pharmaceuticals Ltd. company, in New Delhi 
A cameraman takes visuals outside the office of Maiden Pharmaceuticals Ltd. company, in New Delhi, India, October 6, 2022. REUTERS/Anushree Fadnavis 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4U 
December 02, 2021 
Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4P 
December 02, 2021 
A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4Q 
December 02, 2021 
Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4Y 
December 02, 2021 
A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4X 
December 02, 2021 
A lab employee at Spanish pharmaceutical company Hipra works at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
A lab employee at Spanish pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4O 
December 02, 2021 
Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4V 
December 02, 2021 
Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, poses after an... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, poses after an interview at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4W 
December 02, 2021 
Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, reacts during an... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, reacts during an interview at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
HEALTH-CORONAVIRUS/SPAIN-VACCINE
RTXL0V4S 
December 02, 2021 
A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona,... 
AMER, Spain 
Spain's Hipra eyes European use of COVID-19 vaccine, competition with Novavax 
A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 
BRAZIL-CORRUPTION/VACCINES
RTXHB0YK 
September 17, 2021 
Front of the building of Precisa Medicamentos, a Brazil-based pharmaceutical company, which was raided... 
BARUERI, Brazil 
Federal Police raids Precisa Medicamentos office 
Front of the building of Precisa Medicamentos, a Brazil-based pharmaceutical company, which was raided by Federal Police due possible irregularities in procuring COVID-19 vaccines from India's Bharat Biotech, according to authorities, in Barueri, Brazil September 17, 2021. REUTERS/Carla Carniel 
BRAZIL-CORRUPTION/VACCINES
RTXHB0VV 
September 17, 2021 
Front of the building of Precisa Medicamentos, a Brazil-based pharmaceutical company, which was raided... 
BARUERI, Brazil 
Federal Police raids Precisa Medicamentos office 
Front of the building of Precisa Medicamentos, a Brazil-based pharmaceutical company, which was raided by Federal Police due possible irregularities in procuring COVID-19 vaccines from India's Bharat Biotech, according to authorities, in Barueri, Brazil September 17, 2021. REUTERS/Carla Carniel 
BRAZIL-CORRUPTION/VACCINES
RTXHB0VO 
September 17, 2021 
Front of the building of Precisa Medicamentos, a Brazil-based pharmaceutical company, which was raided... 
BARUERI, Brazil 
Federal Police raids Precisa Medicamentos office 
Front of the building of Precisa Medicamentos, a Brazil-based pharmaceutical company, which was raided by Federal Police due possible irregularities in procuring COVID-19 vaccines from India's Bharat Biotech, according to authorities, in Barueri, Brazil September 17, 2021. REUTERS/Carla Carniel 
BIOTEST-M&A/GRIFOLS
RTXHABCL 
September 17, 2021 
The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in... 
Barcelona, Spain 
The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in... 
The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in Sant Cugat del Valles, near Barcelona, Spain, September 17, 2021. REUTERS/Albert Gea 
BIOTEST-M&A/GRIFOLS
RTXHABCG 
September 17, 2021 
The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in... 
Barcelona, Spain 
The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in... 
The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in Sant Cugat del Valles, near Barcelona, Spain, September 17, 2021. REUTERS/Albert Gea 
CHINA-TRADE/EXPO
RTXGMS32 
September 03, 2021 
The BioNTech logo is seen at the booth of Fosun Pharmaceutical (Group) at the 2021 China International... 
Beijing, China 
The BioNTech logo is seen at the booth of Fosun Pharmaceutical (Group) in Beijing 
The BioNTech logo is seen at the booth of Fosun Pharmaceutical (Group) at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021. REUTERS/Florence Lo 
EU-CANADA/PFIZER
RTXDAX3N 
June 15, 2021 
Canadian Prime Minister Justin Trudeau looks up during a tour of pharmaceutical company Pfizer with Belgian... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau looks up during a tour of pharmaceutical company Pfizer with Belgian counterpart Alexander De Croo (R) in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWVU 
June 15, 2021 
Canadian Prime Minister Justin Trudeau signs a banner during a tour of pharmaceutical company Pfizer... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau signs a banner during a tour of pharmaceutical company Pfizer with Belgian counterpart Alexander De Croo in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWVR 
June 15, 2021 
Canadian Prime Minister Justin Trudeau signs a banner with Belgian counterpart Alexander De Croo and... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau signs a banner with Belgian counterpart Alexander De Croo and speaks to the media during a tour of pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWV8 
June 15, 2021 
Employees check the monitors as Canadian Prime Minister Justin Trudeau gestures during a tour of pharmaceutical... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Employees check the monitors as Canadian Prime Minister Justin Trudeau gestures during a tour of pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWS9 
June 15, 2021 
An employee handles boxes as Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
An employee handles boxes as Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWS8 
June 15, 2021 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWS1 
June 15, 2021 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWEZ 
June 15, 2021 
Canadian Prime Minister Justin Trudeau watches a process during a tour of the pharmaceutical company... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau watches a process during a tour of the pharmaceutical company Pfizer with his Belgian counterpart in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAWEY 
June 15, 2021 
Canadian Prime Minister Justin Trudeau watches as a worker packs a box during a tour of the pharmaceutical... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau watches as a worker packs a box during a tour of the pharmaceutical company Pfizer with his Belgian counterpart in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAW41 
June 15, 2021 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour the pharmaceutical... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour the pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAW3R 
June 15, 2021 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau chat during their... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau chat during their visit to pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAW3P 
June 15, 2021 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau bump arms during... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau bump arms during their visit to pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAVZI 
June 15, 2021 
Canadian Prime Minister Justin Trudeau walks to visit pharmaceutical company Pfizer in Puurs, Belgium... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau walks to visit pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAVZ0 
June 15, 2021 
Canadian Prime Minister Justin Trudeau speaks to the media as he visits pharmaceutical company Pfizer... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau speaks to the media as he visits pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAVWO 
June 15, 2021 
Canadian Prime Minister Justin Trudeau pays a working visit to pharmaceutical company Pfizer in Puurs,... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau pays a working visit to pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
EU-CANADA/PFIZER
RTXDAVWL 
June 15, 2021 
Canadian Prime Minister Justin Trudeau visits pharmaceutical company Pfizer in Puurs, Belgium June 15,... 
PUURS, Belgium 
Canada's PM Trudeau visits Pfizer in Puurs 
Canadian Prime Minister Justin Trudeau visits pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 
HEALTH-CORONAVIRUS/BRAZIL-SPUTNIK
RTXCGX97 
May 20, 2021 
An employee works at the control of quality lab where the Sputnik V vaccines against the coronavirus... 
Guarulhos, Brazil 
The outbreak of the coronavirus disease (COVID-19), in Brazil 
An employee works at the control of quality lab where the Sputnik V vaccines against the coronavirus disease (COVID-19) will be analyzed at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli 
HEALTH-CORONAVIRUS/BRAZIL-SPUTNIK
RTXCGX7S 
May 20, 2021 
Vials containing Sputnik V vaccines against the coronavirus disease (COVID-19) made with ingredients... 
Guarulhos, Brazil 
The outbreak of the coronavirus disease (COVID-19), in Brazil 
Vials containing Sputnik V vaccines against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia are seen at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli 
HEALTH-CORONAVIRUS/BRAZIL-SPUTNIK
RTXCGX7J 
May 20, 2021 
An employee works at the control of quality lab where the Sputnik V vaccines against the coronavirus... 
Guarulhos, Brazil 
The outbreak of the coronavirus disease (COVID-19), in Brazil 
An employee works at the control of quality lab where the Sputnik V vaccines against the coronavirus disease (COVID-19) will be analyzed at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli 
HEALTH-CORONAVIRUS/BRAZIL-SPUTNIK
RTXCGX66 
May 20, 2021 
An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made... 
Guarulhos, Brazil 
The outbreak of the coronavirus disease (COVID-19), in Brazil 
An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli 
HEALTH-CORONAVIRUS/BRAZIL-SPUTNIK
RTXCGX3N 
May 20, 2021 
An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made... 
Guarulhos, Brazil 
The outbreak of the coronavirus disease (COVID-19), in Brazil 
An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli 
HEALTH-CORONAVIRUS/BRAZIL-SPUTNIK
RTXCGWSL 
May 20, 2021 
An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made... 
Guarulhos, Brazil 
The outbreak of the coronavirus disease (COVID-19), in Brazil 
An employee holds a vial containing Sputnik V vaccine against the coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia at Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil May 20, 2021. REUTERS/Amanda Perobelli 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW6O 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW6M 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW6L 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW6K 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5L 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5K 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5J 
May 06, 2021 
Ampules are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
Ampules are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5H 
May 06, 2021 
Tablets are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
Tablets are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5G 
May 06, 2021 
Tablets are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
Tablets are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5F 
May 06, 2021 
A logo of pharmaceutical company Zentiva is seen outside the Zentiva factory in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
A logo of pharmaceutical company Zentiva is seen outside the Zentiva factory in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW5E 
May 06, 2021 
Ampules are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe's drugmakers catching the eye of international investors 
Ampules are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
PHARMACEUTICALS-EASTEUROPE/
RTXCGW3W 
May 06, 2021 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic,... 
Prague, Czech Republic 
Central Europe‚Äôs drugmakers catching the eye of international investors 
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQNIB 
April 23, 2021 
Pfizer CEO Albert Bourla sticks an EU flag label during a visit at the factory of U.S. pharmaceutical... 
PUURS, Belgium 
Pfizer vaccine plant in Puurs 
Pfizer CEO Albert Bourla sticks an EU flag label during a visit at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQN56 
April 23, 2021 
An employee works at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission... 
PUURS, Belgium 
Employees work at Pfizer vaccine plant in Puurs 
An employee works at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission President Ursula von der Leyen (not pictured) to oversee the production of the Pfizer-BioNtech COVID-19 vaccine, in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQN55 
April 23, 2021 
An employee works at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission... 
PUURS, Belgium 
Employees work at Pfizer vaccine plant in Puurs 
An employee works at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission President Ursula von der Leyen (not pictured) to oversee the production of the Pfizer-BioNtech COVID-19 vaccine, in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQN2Q 
April 23, 2021 
Employees work at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission... 
PUURS, Belgium 
Employees work at Pfizer vaccine plant in Puurs 
Employees work at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission President Ursula von der Leyen (not pictured) to oversee the production of the Pfizer-BioNtech COVID-19 vaccine, in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQN2O 
April 23, 2021 
Employees work at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission... 
PUURS, Belgium 
Employees work at Pfizer vaccine plant in Puurs 
Employees work at the factory of U.S. pharmaceutical company Pfizer during a visit by European Commission President Ursula von der Leyen (not pictured) to oversee the production of the Pfizer-BioNtech COVID-19 vaccine, in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQMTG 
April 23, 2021 
European Commission President Ursula von der Leyen addresses a press conference after a visit to oversee... 
PUURS, Belgium 
European Commission President Ursula von der Leyen addresses a press conference after a visit at Pfizer... 
European Commission President Ursula von der Leyen addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQMS2 
April 23, 2021 
CMO and co-founder of German biotechnology company BioNTech Ozlem Tureci, Pfizer CEO Albert Bourla, European... 
PUURS, Belgium 
Press conference after visit at Pfizer vaccine plant in Puurs 
CMO and co-founder of German biotechnology company BioNTech Ozlem Tureci, Pfizer CEO Albert Bourla, European Commission President Ursula von der Leyen and Belgium's Prime Minister Alexander De Croo address a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQM3G 
April 23, 2021 
Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the... 
PUURS, Belgium 
Pfizer CEO Albert Bourla addresses a press conference after a visit at Pfizer vaccine plant in Puurs 
Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
HEALTH-CORONAVIRUS/EU-PFIZER
RTXBQM3F 
April 23, 2021 
Pfizer CEO Albert Bourla adjusts his face mask during a press conference after a visit to oversee the... 
PUURS, Belgium 
Pfizer CEO Albert Bourla addresses a press conference after a visit at Pfizer vaccine plant in Puurs 
Pfizer CEO Albert Bourla adjusts his face mask during a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys /Pool via REUTERS 
Sort by 
Display 
Items per page 
Page 
of 33